Trial Profile
Efficacy and Long-Term Safety of SK-0403 as Add-on Therapy to Glinides in Patients with Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kowa; Sanwa Kagaku Kenkyusho
- 22 Dec 2014 New trial record